Ornithine decarboxylase turnover slowed by alpha-hydrazino-ornithine.
D000818:Animals; D001921:Brain / Q000201:enzymology; D002250:Carbon Radioisotopes; D002262:Carboxy-Lyases / Q000037:antagonists & inhibitors / Q000378:metabolism*; D006528:Carcinoma, Hepatocellular / Q000201:enzymology; D003513:Cycloheximide / Q000494:pharmacology; D004229:Dithiothreitol / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D006207:Half-Life; D006834:Hydrazines / Q000494:pharmacology*; D066298:In Vitro Techniques; D007668:Kidney / Q000502:physiology; D008099:Liver / Q000201:enzymology; D008113:Liver Neoplasms / Q000201:enzymology; D008115:Liver Regeneration; D009392:Nephrectomy; D009952:Ornithine / Q000494:pharmacology*; D011732:Pyridoxal Phosphate / Q000494:pharmacology; D051381:Rats; D013268:Stimulation, Chemical; D013997:Time Factors
D002250:Carbon Radioisotopes; D006834:Hydrazines; D011732:Pyridoxal Phosphate; D003513:Cycloheximide; D009952:Ornithine; D002262:Carboxy-Lyases; D004229:Dithiothreitol